ELTROMBOPAG

Description

Eltrombopag

Eltrombopag – Oral Platelet Growth Stimulator for Blood Disorders

Eltrombopag is an oral prescription medicine used to treat thrombocytopenia (low platelet count) associated with certain blood disorders. Classified as a thrombopoietin receptor agonist (TPO-RA), Eltrombopag stimulates the production of platelets in the bone marrow, helping to reduce the risk of bleeding in patients with low platelet counts.

It is commonly prescribed for patients with chronic immune thrombocytopenia (ITP), aplastic anemia, and thrombocytopenia related to chronic hepatitis C infection.

At Oncomed Pharmacy, we provide genuine Eltrombopag tablets from trusted manufacturers, ensuring patients have access to safe, effective, and high-quality hematology and oncology supportive care medicines.

Key Features of Eltrombopag

• Indications:

o Chronic immune thrombocytopenia (ITP) unresponsive to other treatments

o Severe aplastic anemia (SAA)

o Thrombocytopenia in chronic hepatitis C infection

• Formulation: Oral tablets, available in multiple strengths.
• Mechanism of Action: Thrombopoietin receptor agonist that promotes platelet production in the bone marrow.
• Patient Benefit: Helps increase platelet counts, reduces bleeding risks, and supports patients undergoing cancer treatment or antiviral therapy.

Why Buy Eltrombopag from Oncomed Pharmacy?

• 100% authentic and quality-tested hematology medicines.
• Affordable prices with secure countrywide delivery.
• Multiple dosage strengths available for personalized treatment.
• Trusted supplier specializing in oncology and supportive care treatments.

Uses of Eltrombopag

• Treatment of chronic ITP in adults and children.
• Supportive therapy for severe aplastic anemia.
• Management of low platelets in hepatitis C patients to allow continuation of antiviral therapy.
• May be used in combination with other medications for improved outcomes.